Biotech · Private company
Prometheus Laboratories
Track this companyFree. Adds Prometheus Laboratories to your Dealase workspace and tells you when its record changes.
Clinical trials124 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CROWNPhase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ColonoscopyCrohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney CancerPHASE1 · TERMINATED · started Aug 28, 2018ClinicalTrials.gov NCT03260504 · fetched Nov 12, 2026
- Anti-PD-1 Antibody With HD IL-2 in Metastatic MelanomaPHASE2 · TERMINATED · started May 7, 2018ClinicalTrials.gov NCT03476174 · fetched Nov 12, 2026
- Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) PatientsNA · TERMINATED · started May 4, 2018ClinicalTrials.gov NCT03566407 · fetched Nov 12, 2026
- Interleukin-2 and Pembrolizumab for Metastatic Kidney CancerPHASE2 · COMPLETED · started Apr 25, 2017ClinicalTrials.gov NCT02964078 · fetched Nov 12, 2026
- Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF TherapyPHASE2 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02793778 · fetched Nov 12, 2026
- A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHDPHASE2 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02340676 · fetched Nov 12, 2026
- Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 1, 2014ClinicalTrials.gov NCT02306954 · fetched Nov 12, 2026
- HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic MelanomaPHASE4 · TERMINATED · started Aug 1, 2012ClinicalTrials.gov NCT01683188 · fetched Nov 12, 2026
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in MalignancyCOMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01415167 · fetched Nov 12, 2026
- Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 1, 2011ClinicalTrials.gov NCT01416831 · fetched Nov 12, 2026
- Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jul 1, 2011ClinicalTrials.gov NCT01366092 · fetched Nov 12, 2026
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic MelanomaPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 1, 2006ClinicalTrials.gov NCT00338377 · fetched Nov 12, 2026